The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.
The treatment is formulated with Teva's proprietary abuse-deterrent technology.
US FDA approves Teva Pharmaceutical's pain medication
Climate Credit Analytics: Linking climate scenarios to financial impacts
Global M&A Infographic Q1 2021
Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge
COVID-19 Impact & Recovery: Private Equity
US FDA approves Teva Pharmaceutical's pain medication
- Author Muhammad Ahmer Gul Khan
- Theme Healthcare & Pharmaceuticals